Work

TGFΒ/SMAD4 Signaling and Altered Epigenetics Contribute to Increased Ovarian Cancer Severity

Year: 2011
Type: article
Study design: Observational Study
Abstract: Ovarian cancer is the eighth most common cancer and is the fifth most common cause of cancer related death among women.Early stage ovarian cancer is very responsive to treatments and more than 93% of patients diagnosed with early stage disease achieve a five year survival rate.By contrast less than 30% of patients who are diagnosed with late stage disease achieve a five year survival rate, yet more than 60% of all cases present as late stage.Treatment options are typically surgery followed by a combination chemotherapy regiment of a platinum-based chemotherapeutic and a taxane derivative.While this treatment plan works well for early stage disease, recurrent and late stage disease are less responsive and secondary treatment options are not nearly as beneficial.Here we present work investigating the altered epigenetics and TGFβ/SMAD4 signaling pathway in ovarian cancer in an effort to better understand the difference in disease severity at a molecular level.We have identified a microRNA hsa-mir-9-3 which is epigenetically repressed by DNA methylation in a panel of primary ovarian cancer patients.Quantitative analysis of DNA methylation in the CpG island which contains the hsa-mir-9-3 microRNA revealed significant hypermethylation in both patient samples and cell lines as compared to normal tissue samples.Although no regulation following TGFβ stimulation may play a key role in ovarian carcinogenesis.Additionally, we identified a novel biomarker, CLDN11, whose epigenetic repression is associated increased cisplatin resistance in a tissue culture model system.Examination of CLDN11 expression levels in a previously reported patient cohort revealed lower expression levels associated with increased tumor grade.Finally, loss of CLDN11 expression is associated with increased cellular motility.In conclusion we have investigated and correlated several different epigenetic and signaling abnormalities associated with an increase in the severity of ovarian cancer while demonstrating the importance of recent technological advances in genome-wide methodologies.Together these results are likely to aid in both future discovery methods as well as patient prognosis and treatment.v Dedication To my wife whose love and reminders to eat and live while writing this showed me writing, living, eating, and loving can be multitasked.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W2266139338
FWCI:
Cites: 164
Cited by:
Related to: 10